Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · CellCept

CellCept 500 mg powder for concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 33

HOS-085288 · Präparat HOS-083095

(MedDRA) Renal Hepatic transplant transplant System Organ Class Frequency Frequency Infections and infestations Bacterial infections Very Common Very Common Fungal infections Common Very Common Protozoal infections Uncommon Uncommon Viral infections Very Common Very Common Neoplasms benign, malignant and unspecified (including cysts and polyps) Benign neoplasm of skin Common Common Lymphoma Uncommon Uncommon Lymphoproliferative disorder Uncommon Uncommon Neoplasm Common Common Skin cancer Common Uncommon Blood and lymphatic system disorders Anaemia Very Common Very Common Aplasia pure red cell Uncommon Uncommon Bone marrow failure Uncommon Uncommon Ecchymosis Common Common Leukocytosis Common Very Common Leukopenia Very Common Very Common Pancytopenia Common Common Pseudolymphoma Uncommon Uncommon Thrombocytopenia Common Very Common Metabolism and nutrition disorders Acidosis Common Common Hypercholesterolaemia Very Common Common Hyperglycaemia Common Very Common Hyperkalaemia Common Very Common Hyperlipidaemia Common Common Hypocalcaemia Common Very Common Hypokalaemia Common Very Common Hypomagnesaemia Common Very Common Hypophosphataemia Very Common Very Common

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.